Client-focused approach and integration of best-in-class formulation throughout the development process create significant value and speed time-to-market Companies celebrate fourth anniversary of ...

Leukocare AG, a German biotechnology company specialized in formulation development for biologics, viral vectors and vaccines, today announced the opening of its development laboratories and offices ...

- First project covers formulation development for a biosimilar of a blockbuster therapeutic antibody Munich - Formycon AG (ISIN: DE000A1EWVY8/ WKN: A1EWVY) and Leukocare AG today announced a ...

Leukocare AG, a biotechnology company specialized in the field of biopharmaceutical formulation development, today announced the closing of a USD 17.5 million (EUR 14.6 million) financing, led by ...

ROME, MUNICH and BRUSSELS, April 23, 2020 /PRNewswire/ -- Italian ReiThera Srl. (Rome), German LEUKOCARE AG (Munich), and Belgian Univercells S.A. (Brussels), today announced a strategic collaboration ...

LEUKOCARE AG and Xellia Pharmaceuticals, have entered into a global strategic partnership, where both companies will collaborate closely to discover innovative and superior formulations to support the ...

Leukocare AG, a biotechnology company specialized in the field of biopharmaceutical formulation development, today announced the introduction of a new management structure, effective July 1st, 2022, ...

MUNICH, March 25, 2019 /PRNewswire/ -- Dr Andreas Seidl, hired as new Chief Operating Officer and member of the Executive Board, will be responsible for managing R&D operations as well as quality and ...

Leukocare AG, a biotechnology company specialized in the field of biopharmaceutical formulation development, today announced that Dr. Dirk Winnemöller took up the newly established role as Vice ...

Collaborative partnerships can foster success in formulation development projects. The formulation development outsourcing market is expected to grow at a compound annual rate of 7.2% between 2021 and ...